EHS
EHS

Does Aspirin Cut the Risk of Initial Vascular Events in Patients at Moderate CVD Risk?

For this double-blind, placebo-controlled study, researchers selected male patients ≥55 years and female patients ≥60 years with average cardiovascular risk and assigned them to enteric-coated aspirin 100mg (N=6270) or placebo (N=6276) once daily; the median follow-up time was 60 months.

Source link

EHS
Back to top button